AzTrials
AzTrials

Molar Incisor HypomineralisationNCT07850986

Pain Assessment Governing Partial or Full Pulpotomy of Immature Molars With Irreversible Pulpitis in Molar Incisor Hypomineralization

A study testing pulpotomy for MIH affected immature PFMs, partial pulpotomy for MIH affected immature PFMs and pulpotomy for non-MIH affected immature PFMs in people with Molar Incisor Hypomineralisation and Irreversible Pulpitis, run by Alaa Khafagy at 1 site in Egypt.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record

Search all trials

Trial summary

This randomized controlled clinical trial aims to evaluate and compare pain levels associated with partial pulpotomy (PP) and full pulpotomy (FP) in immature permanent first molars diagnosed with irreversible pulpitis. Read more about this study

Who is it for?
Ages 6 to 8 yearsHealthy volunteers can take part
What is being tested?
pulpotomy for MIH affected immature PFMs, partial pulpotomy for MIH affected immature PFMs and pulpotomy for non-MIH affected immature PFMs
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
132 participants
Where
1 siteEgypt
Study dates
1 May 2026to 30 Oct 2026
Phase
Interventional

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 8 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Age ranges from 6 - 8 years.
  • Children free of any systemic disease or special health care need (ASA I).
  • Positive or definitely positive behavior during preoperative assessments
  • according to the Frankl Rating Scale (score 3 or 4).
  • Patients whose parents will give their written consent to participate.
  • MIH-affected PFMs with Treatment Need index (TNI) 4c).
Show all 16Show fewer
  • Schiff Cold Air Sensitivity Scale (SCASS) scores 2 and 3.
  • Restorable MIH-affected PFMs associated with signs and symptoms of irreversible pulpitis
  • Spontaneous, unprovoked pain
  • Lingering pain after thermal stimulus.
  • Exacerbation by postural changes.
  • Referred pain.
  • Nocturnal pain.
  • Haemostasis achieved within 10 minutes
  • Negative response to percussion and palpation
  • Restorable non-MIH-affected PFMs associated with signs and symptoms of irreversible pulpitis.

Who cannot join

  • Medically compromised patients.
  • Allergies to local anesthesia.
  • Intolerance to NSAIDs.
  • Patients with Frankl scores 1 and 2.
  • Patients who took analgesics or antibiotics in the last 12 hours.
  • Non-restorable permanent first molars.
Show all 14Show fewer
  • Non-vital permanent first molars (negative response to pulp testing).
  • Tooth mobility with grades 2 and 3.
  • pocket depth greater than 5 mm.
  • Radiographic evidence of vertical root fracture, perforation, and/or peri-apical radiolucency.
  • Widening of periodontal ligament.
  • Pain on percussion.
  • Uncontrolled puplpal haemorrhage lasting more than 10 minutes
  • Degenerating pulp

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Faculty of Dentistry, Alexandria University

    Alexandria, Alexandria Governorate, 555

Other trials in Egypt

About this study

Official title: Pain Assessment Governing Partial or Full Pulpotomy of Immature Molars With Irreversible Pulpitis in Molar Incisor Hypomineralization (a Randomized Controlled Clinical Trial)

This randomized controlled clinical trial aims to evaluate and compare pain levels associated with partial pulpotomy (PP) and full pulpotomy (FP) in immature permanent first molars diagnosed with irreversible pulpitis. The study specifically investigates differences between molars affected by molar incisor hypomineralization (MIH) and those without MIH.

A total of 132 children aged 6-8 years will be randomly allocated into four groups based on MIH status and type of pulpotomy. All participants will receive pre-emptive ibuprofen prior to treatment. Pain will be assessed preoperatively, intraoperatively, and postoperatively using validated scales.

The study aims to evaluate pre-, intra-, and postoperative pain levels after partial pulpotomy (PP) and full pulpotomy (FP) in MIH-affected immature permanent first molars (PFMs) with irreversible pulpitis.

Read the detailed description

This study is a four-arm, parallel-group, single-blinded randomized controlled clinical trial designed to evaluate pain associated with vital pulp therapy in immature permanent first molars (PFMs) diagnosed with irreversible pulpitis.

The trial will include 132 children aged 6 to 8 years presenting with either MIH-affected or non-MIH-affected immature PFMs requiring treatment. Eligible teeth will be stratified based on the presence of molar incisor hypomineralization (MIH), then randomly assigned to receive either full pulpotomy (FP) or partial pulpotomy (PP), resulting in four study groups:

  1. MIH + FP
  2. MIH + PP
  3. Non-MIH + FP
  4. Non-MIH + PP

All participants will receive pre-emptive analgesia using ibuprofen (25 mg/kg) one hour prior to treatment to enhance pain control.

The primary outcome is pain assessment at multiple time points: preoperative, intraoperative, and postoperative (4, 6, 12, 24, and 48 hours, and 1 week). Pain will be evaluated using the Wong-Baker Faces Pain Rating Scale (subjective) and FLACC scale (objective).

Secondary outcomes include:

  • Patient cooperation assessed using the Frankl Behavioral Rating Scale
  • Patient satisfaction assessed using a 5-point Likert scale
  • Patient anxiety assessed objectively using pulse oximeter pre- and intraoperatively

All procedures will be performed under standardized clinical protocols using local anesthesia, rubber dam isolation, and biocompatible pulp capping materials. Final restorations will be completed using stainless steel crowns.

The study follows CONSORT guidelines and aims to provide evidence on the effectiveness of partial versus full pulpotomy in pain management, particularly in MIH-affected immature molars, where altered pulp characteristics may influence pain perception and treatment outcomes.

Being tested
pulpotomy for MIH affected immature PFMs, partial pulpotomy for MIH affected immature PFMs, pulpotomy for non-MIH affected immature PFMs, partial pulpotomy for non-MIH affected immature PFMs
Keywords
MIH-Affected Immature Molars, Irreversible Pulpitis, Pulpotomy, Partial Pulpotomy
Medical subject headings
Molar Hypomineralization

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • pulpotomy for MIH affected immature PFMsProcedure or surgery

    Step-by-step pulpotomy procedure for MIH affected immature PFMs

  • partial pulpotomy for MIH affected immature PFMsProcedure or surgery

    Step-by-step partial pulpotomy procedure for MIH affected immature PFMs

  • pulpotomy for non-MIH affected immature PFMsProcedure or surgery

    Step-by-step pulpotomy procedure for non-MIH affected immature PFMs

  • partial pulpotomy for non-MIH affected immature PFMsProcedure or surgery

    Step-by-step partial pulpotomy procedure for non-MIH affected immature PFMs

Study groups in NCT07850986
Study groupRoleWhat they receive
Group IA (n=33)ExperimentalStep-by-step pulpotomy procedure for MIH affected immature PFMs
Receives: Procedure: pulpotomy for MIH affected immature PFMs
Group IB (n=33)ExperimentalStep-by-step partial pulpotomy procedure for MIH affected immature PFMs
Receives: Procedure: partial pulpotomy for MIH affected immature PFMs
Group IIA (n=33)Active comparatorStep-by-step pulpotomy procedure for non-MIH affected immature PFMs
Receives: Procedure: pulpotomy for non-MIH affected immature PFMs
Group IIB (n=33)Active comparatorStep-by-step partial pulpotomy procedure for non-MIH affected immature PFMs
Receives: Procedure: partial pulpotomy for non-MIH affected immature PFMs

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. pain evaluation

    To evaluate pre-, intra-, and postoperative pain levels after partial pulpotomy (PP) and full pulpotomy (FP) in MIH-affected immature permanent first molars (PFMs) with irreversible pulpitis using Wong-Baker's pain rating scale.

    minimum value=0 better outcome maximum value=10 worse outcome

    Measured: one week

Secondary outcomes (4)
  1. pain comparison

    To compare pain levels (pre-, intra-, and postoperative) between PP and FP in MIH-affected and non-MIH-affected immature PFMs with irreversible pulpitis using Wong-Baker's pain rating scale.

    minimum=0 better outcome maximum=10 worse outcome

    Measured: one week

  2. patient satisfaction

    To compare patient satisfaction after PP and FP in MIH-affected and non-MIH-affected immature PFMs with irreversible pulpitis using 5-point likert scale.

    minimum (very dissatisfied) =0 maximum (very satisfied) =5

    Measured: after 1 week

  3. patient cooperation

    To compare patient cooperation during PP and FP in MIH-affected and non-MIH-affected immature PFMs with irreversible pulpitis using Frankl scale.

    minimum (definitely negative) (rating score 1) maximum (definitely positive) (rating scale 4)

    Measured: 1 day

  4. Patient anxiety

    Evaluate physiological stress and anxiety preoperatively and intraoperatively objectively by recording heart rate using a pulse oximeter

    Measured: 1 day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Oct 2026
  2. Study start1 May 2026
  3. Primary completion30 Oct 2026 (estimated)
  4. Study completion30 Oct 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
132 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07850986
Sponsor's protocol ID
1225-01/2026
Status last verified
Sep 2026
First submitted
20 Sep 2026
Last updated
1 Oct 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in